Masatoshi Tanaka
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 25, 2024
Efficacy of Atezolizumab Plus Bevacizumab-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.Etsuko Moriyama, Shigeo Shimose, Takashi Niizeki
|Sep 28, 2023
Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching.Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki
|Sep 23, 2022
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma.Shigeo Shimose, Atsushi Hiraoka, Andrea Casadei-Gardini
|Sep 09, 2022
Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka
|Jul 02, 2021
Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice.Hideki Iwamoto, Shigeo Shimose, Yu Noda
Pageof 1
